LONDON/PARIS - Britain has signed a supply deal for up to 60 million doses of a possible Covid-19 vaccine being developed by Sanofi and GlaxoSmithKline , it said on Wednesday , its fourth such arrangement.
Britain has moved early in striking vaccine supply deals, and ministers have stressed the importance of securing supplies of a range of candidates."In the meantime, it is important that we secure early access to a diverse range of promising vaccine candidates, like GSK and Sanofi, to increase our chances of finding one that works."
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
EU talks with Pfizer, Sanofi, J&J on Covid-19 vaccines hit snags: SourcesBRUSSELS (REUTERS) - European efforts to secure potential Covid-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method and potential liability costs, three EU officials told Reuters.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags - sourcesEuropean efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags: SourcesEuropean efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Japan's Fujifilm gets US$265 million US contract to boost output of potential COVID-19 vaccineTOKYO: The United States has awarded a US$265 million contract to a Texas facility of Japan's Fujifilm Holdings to step up production of a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Declining Covid-19 cases led Chinese firms to abort vaccine trials in Malaysia, says ministerKUALA LUMPUR (THE STAR/ASIA NEWS NETWORK) - Several companies from China pulled out from clinical trials on Covid-19 vaccines in Malaysia owing to a decline in cases in the country, Science, Technology and Innovation Minister Khairy Jamaluddin said on Tuesday (July 28).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Pfizer profit falls 32per cent as global trial of COVID-19 vaccine candidate beginsPfizer Inc reported a 32per cent fall in second-quarter profit on Tuesday due to a dip in demand for some of its drugs from the COVID-19 pandemic ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »